Severity of stimulant use disorder by psychostimulant type and polystimulant use pattern.

IF 2.4 3区 医学 Q3 PHARMACOLOGY & PHARMACY
Experimental and clinical psychopharmacology Pub Date : 2025-06-01 Epub Date: 2025-02-27 DOI:10.1037/pha0000761
Ty S Schepis, Philip T Veliz, Vita V McCabe, Kennedy S Werner, Emily Pasman, Timothy E Wilens, Sean Esteban McCabe
{"title":"Severity of stimulant use disorder by psychostimulant type and polystimulant use pattern.","authors":"Ty S Schepis, Philip T Veliz, Vita V McCabe, Kennedy S Werner, Emily Pasman, Timothy E Wilens, Sean Esteban McCabe","doi":"10.1037/pha0000761","DOIUrl":null,"url":null,"abstract":"<p><p>Psychostimulant misuse and use disorders are major drivers of morbidity and fatal overdose in the United States, but little is known about how differences in psychostimulant use patterns relate to <i>Diagnostic and Statistical Manual, Diagnostic and Statistical Manual of</i> <i>Mental Disorders, 4th edition and Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5)</i> stimulant substance use disorder (SUD) profiles. We used nationally representative U.S. data to assess the links between polystimulant use patterns and stimulant SUD prevalence, symptom counts, and <i>DSM-5</i> stimulant SUD severity. Data were from the 2015-2019 and 2020 National Survey on Drug Use and Health. Participants (<i>n</i> = 282,786) were grouped by past-year psychostimulant use patterns: (a) nonmedical use of prescription stimulants (NUPS) only; (b) cocaine-only; (c) methamphetamine-only; and (d) polystimulant use. Analyses comparing groups used logistic regressions for prevalence of past-year <i>Diagnostic and Statistical Manual of Mental Disorders, 4th edition</i> (2015-2019 and 2020) and <i>DSM-5</i> (2020 only) stimulant SUD, negative binomial regressions for stimulant SUD symptom counts, and multinomial regressions for DSM-5 stimulant SUD severity. Those with past-year methamphetamine-only or polystimulant use had significantly higher <i>Diagnostic and Statistical Manual of Mental Disorders, 4th edition</i> and <i>DSM-5</i> prevalence rates, symptom counts, and DSM-5 severities of stimulant SUD than those with NUPS or cocaine use only. Depending on <i>Diagnostic and Statistical Manual of Mental Disorders</i> version, 34%-47% of those engaged in polystimulant use and 48%-54% of those with methamphetamine use only met criteria for a stimulant SUD, versus 9%-17% for NUPS-only and 16%-24% for cocaine-only. For 2020, roughly two thirds of those with methamphetamine-only use had stimulant SUD symptoms. Individuals with methamphetamine and/or polystimulant use may have different service needs than those with NUPS or cocaine use only. (PsycInfo Database Record (c) 2025 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":" ","pages":"275-284"},"PeriodicalIF":2.4000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097928/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and clinical psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1037/pha0000761","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Psychostimulant misuse and use disorders are major drivers of morbidity and fatal overdose in the United States, but little is known about how differences in psychostimulant use patterns relate to Diagnostic and Statistical Manual, Diagnostic and Statistical Manual of Mental Disorders, 4th edition and Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) stimulant substance use disorder (SUD) profiles. We used nationally representative U.S. data to assess the links between polystimulant use patterns and stimulant SUD prevalence, symptom counts, and DSM-5 stimulant SUD severity. Data were from the 2015-2019 and 2020 National Survey on Drug Use and Health. Participants (n = 282,786) were grouped by past-year psychostimulant use patterns: (a) nonmedical use of prescription stimulants (NUPS) only; (b) cocaine-only; (c) methamphetamine-only; and (d) polystimulant use. Analyses comparing groups used logistic regressions for prevalence of past-year Diagnostic and Statistical Manual of Mental Disorders, 4th edition (2015-2019 and 2020) and DSM-5 (2020 only) stimulant SUD, negative binomial regressions for stimulant SUD symptom counts, and multinomial regressions for DSM-5 stimulant SUD severity. Those with past-year methamphetamine-only or polystimulant use had significantly higher Diagnostic and Statistical Manual of Mental Disorders, 4th edition and DSM-5 prevalence rates, symptom counts, and DSM-5 severities of stimulant SUD than those with NUPS or cocaine use only. Depending on Diagnostic and Statistical Manual of Mental Disorders version, 34%-47% of those engaged in polystimulant use and 48%-54% of those with methamphetamine use only met criteria for a stimulant SUD, versus 9%-17% for NUPS-only and 16%-24% for cocaine-only. For 2020, roughly two thirds of those with methamphetamine-only use had stimulant SUD symptoms. Individuals with methamphetamine and/or polystimulant use may have different service needs than those with NUPS or cocaine use only. (PsycInfo Database Record (c) 2025 APA, all rights reserved).

兴奋剂使用障碍的严重程度按精神兴奋剂类型和多兴奋剂使用模式划分。
精神兴奋剂滥用和使用障碍是美国发病率和致命过量的主要驱动因素,但关于精神兴奋剂使用模式的差异与《诊断与统计手册》、《精神疾病诊断与统计手册》第4版和《精神疾病诊断与统计手册》第5版(DSM-5)兴奋剂物质使用障碍(SUD)概况的关系知之甚少。我们使用具有全国代表性的美国数据来评估多兴奋剂使用模式与兴奋剂性SUD患病率、症状计数和DSM-5兴奋剂性SUD严重程度之间的联系。数据来自2015-2019年和2020年全国药物使用与健康调查。参与者(n = 282,786)按过去一年精神兴奋剂使用模式分组:(a)仅使用处方兴奋剂(NUPS)的非医疗使用;(b)可卡因——;(c) methamphetamine-only;(d)使用多种兴奋剂。比较各组的分析使用逻辑回归分析过去一年精神障碍诊断与统计手册第4版(2015-2019和2020)和DSM-5(仅2020年)兴奋剂性SUD的患病率,使用负二项回归分析兴奋剂性SUD症状计数,使用多项回归分析DSM-5兴奋剂性SUD严重程度。过去一年仅使用甲基苯丙胺或多种兴奋剂的患者与仅使用NUPS或可卡因的患者相比,在《精神障碍诊断与统计手册》第4版和DSM-5中的患病率、症状计数和兴奋剂SUD的严重程度均显著高于后者。根据《精神疾病诊断与统计手册》的版本,34%-47%使用多种兴奋剂的患者和48%-54%仅使用甲基苯丙胺的患者符合兴奋剂SUD的标准,而仅使用nups的患者为9%-17%,仅使用可卡因的患者为16%-24%。到2020年,大约三分之二只使用甲基苯丙胺的人出现了兴奋剂性SUD症状。使用甲基苯丙胺和/或多种兴奋剂的个人可能与仅使用NUPS或可卡因的人有不同的服务需求。(PsycInfo Database Record (c) 2025 APA,版权所有)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.20
自引率
8.70%
发文量
164
审稿时长
6-12 weeks
期刊介绍: Experimental and Clinical Psychopharmacology publishes advances in translational and interdisciplinary research on psychopharmacology, broadly defined, and/or substance abuse.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信